Antje Blumenthal hones in on new TB drugs
University of Queensland scientists are honing in on drug-resistant tuberculosis (TB) in a project which could lead to new antibiotics.
The UQ team has identified four new classes of compounds which act against TB bacteria, and hopes commercialisation activities could begin within two to three years.
Dr Antje Blumenthal from the UQ Diamantina Institute (UQDI) said the team would now build on that research by prioritising and optimising the most promising potential drug candidates.